Top View
- Autoimmune Progesterone Dermatitis: a Complex 6
- 210115Orig1s000
- The Drug-Drug Interaction Potential of Antiviral Agents for the Treatment of Chronic Hepatitis C Infection
- Hazardous Drug List Gown, Eye and Face Protection in Low (Yellow) - Handle at All Times with Gloves and Appropriate Addition to Any Necessary Engineering Controls
- Pharmacological Drugs Inducing Ototoxicity, Vestibular Symptoms and Tinnitus: a Reasoned and Updated Guide
- Apple Health Medicaid: Fee-For-Service Preferred Drug List
- Australian Public Assessment Report for Tacrolimus
- Korlym (Mifepristone)
- Treatment on Meiotic Chromosomes in Testes, Epididymal Spermatozoa and Fertility in Swiss Albino Male Mice
- Influence of Mycophenolic Acid and Tacrolimus on Homocysteine
- Posttransplantation Tuberculosis Management in Terms of Immunosuppressant Cost
- Mifepristone (Korlym) Reference Number: ERX.SPA.15 Effective Date: 07.01.16 Last Review Date: 02.21 Line of Business: Commercial, Medicaid Revision Log
- Pharmacokinetic Drug–Drug Interaction Study Between Clindamycin and Cyclosporin in Rabbits
- Drug Safety Update
- Clinicaltrials.Gov Identifier: NCT02099864 Oregon Health & Science University OHSU Knight Cancer Institute OHSU Eirb Protocol #: 10241
- NIOSH List of Antineoplastic and Other Hazardous Drugs in Healthcare Settings, 2014
- Protopic (Tacrolimus) Medication Guide
- Medication Guidelines for Solid Organ Transplants
- Induction of Rosaceiform Dermatitis During Treatment of Facial Inflammatory Dermatoses with Tacrolimus Ointment
- Prograf® (Pdf 657
- PEDIATRIC PHARMACOTHERAPY a Monthly Newsletter for Health Care Professionals from the Children’S Medical Center at the University of Virginia
- Short-Term Treatment with Mycophenolic Acid and Tacrolimus
- Tacrolimus Therapy for Management of Oral Chronic GVHD
- Drug Interactions Between Antimicrobial And
- Medication Guide KORLYM® (KOR-Lim) (Mifepristone) Tablets
- Tacforius, Tacrolimus
- Ketoconazole) Tablets
- 10-11-2017 Relationship Between Plasma Concentration of 17
- Management of Chronic Hyperkalemia in Patients with Chronic Kidney Disease: an Old Problem with News Options
- PROGRAF (Tacrolimus) Injection, (For Intravenous Use) Viremia and Disease; Consider Reducing Immunosuppression (5.5) Initial U.S
- Tacrolimus Improves the Implantation Rate In
- Therapeutic Potentials of Low-Dose Tacrolimus for Aberrant Endometrial Features in Polycystic Ovary Syndrome
- New Zealand Data Sheet Tacrolimus Sandoz Capsules (Tacrolimus) 1
- Reference ID: 4817385 FULL PRESCRIBING INFORMATION
- FEP 5 Tier Managed Rx Drug Formulary (807) Basic Option
- Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate
- Korlym (Mifepristone) C10881-A
- (April 2005) Drug Interactions with Hormonal Contraception
- Anaphylaxis to Clindamycin Following Cutaneous Exposure N
- Drugs Associated with Qt Interval Prolongation2–65
- Guide to the Management of Kidney Transplant Recipients
- Topical Steroid Withdrawal in Atopic Dermatitis
- PROGRAF®Tacrolimus Capsulestacrolimus
- Pathophysiology and Treatment of Calcineurin Inhibitor Nephrotoxicity Jonna Kemper St
- Tacrolimus Accord 0.1 % Ointment
- Drug-Drug Interactions of Tacrolimus A
- Combination Therapy of Tetracycline and Tacrolimus Resulting in Rapid Resolution of Steroid-Induced Periocular Rosacea
- KORLYM™ (Mifepristone) Oral Tablet
- Macrolide Allergic Reactions
- Avagraf, INN-Tacrolimus
- Tacrolimus Ointment 0.1% Produces Repigmentation in Patients with Vitiligo: Results of a Prospective Patient Series
- Kidney Transplant Guide
- Article Randomized, Controlled Trial of Tacrolimus and Prednisolone
- The Effect of Spironolactone on Calcineurin Inhibitor Induced Nephrotoxicity: a Multicenter Randomized, Double-Blind, Clinical T
- Combination of Ketoconazole and Tacrolimus Increases the Risk of Kidney Transplant Rejection in African Americans
- Medicines for Keeping Your Transplanted Organ Healthy